Marimed (MRMD) Free Cash Flow (2013 - 2026)

Marimed (MRMD) has reported Free Cash Flow for 14 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Free Cash Flow rose 216.58% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $7.0 million, a 254.89% increase from a year earlier, with the FY2025 full-year figure at $5.1 million, up 198.34% from the prior year.
• Free Cash Flow was $1.5 million for Q2 2026 at Marimed, up from $576000.0 in the prior quarter.
• Over five years, Free Cash Flow peaked at $5.9 million in Q3 2023 and troughed at -$7.7 million in Q2 2022.
• A 5-year average of -$54111.1 and a median of -$141500.0 in 2023 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow soared 1688.0% in 2024 and tumbled 690.51% in 2025, its largest moves.
• Over 5 years, Free Cash Flow stood at -$418000.0 in 2022, then tumbled by 413.64% to -$2.1 million in 2023, then soared by 31.49% to -$1.5 million in 2024, then soared by 339.97% to $3.5 million in 2025, then plunged by 56.97% to $1.5 million in 2026.
• The last three Free Cash Flow figures came in at $1.5 million (Q2 2026), $576000.0 (Q1 2026), and $3.5 million (Q4 2025), per Business Quant data.